Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Award in Geriatric Gastroenterology and by a T. Franklin Williams Scholarship Award. Funding provided by Atlantic Philanthropies, the37 passages
• Award in Geriatric Gastroenterology and by a T. Franklin Williams Scholarship Award; Funding provided by: Atlantic Philanthropies, Inc., the42 passages
• Award in Geriatric Gastroenterology and by a T. Franklin Williams Scholarship Award; funding provided by: Atlantic Philanthropies, Inc; the29 passages
• Award in Liver Disease to N.S., the University of Texas System Rising STARs award to N.S., and the University Center Foundation via the Institutional Research Grant program at the University of36 passages
• Biomedical Research Centre at Guy's and St39 passages
• Biomedical Research Centres at Guy's and St Thomas’ NHS Foundation Trust and King's College London and Imperial College37 passages
• Branch, Division of Digestive Diseases and Nutrtion, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of HealthBethesda, MDAddress reprint requests to:26 passages
• Brisbane, Australia5 Department of Gastroenterology, Case Western Reserve University, and Department of Gastroenterology and Hepatology, The Cleveland ClinicCleveland, OHAddress reprint requests to:53 passages
• Centre); Isaac Newton Trust; Addenbrooke's Charitable Trust;45 passages
• Centres based at Imperial College28 passages
• Collaboration, D. E. J. Jones has received funding from GSK, Intercept and Pfizer, provided consultancy advice to Novartis, GSK and Intercept and has given sponsored lectures for Falk.33 passages
• Council (MRC) Cancer Cell Unit, Hutchison/MRC Research CentreCambridge, UK4 Department of Pathology, University of CambridgeCambridge, UKAddress reprint requests to: Dr.32 passages
• Council (STOP‐HCV3 passages
• Council, and Cancer33 passages
• CouncilSFB974KFO217LA‐2558/5‐1Jürgen Manchot Graduate26 passages
• EditorialsData supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States GISH ET AL.Gish9 passages
• EditorialsRegulation of retinol‐binding protein 4 and retinol metabolism in fatty liver disease Hepatology, Vol. XX, No. X, 2016 Romeo and ValentiRomeo and ValentiRomeo5 passages
• Expanded Classification of23 passages
• Foundation of Korea funded by the Ministry of Education, Science and29 passages
• Foundation. Genotyping in the24 passages
• Funds, Dutch Prevention Funds,42 passages
• Glasgow, UK2 Department of Medicine, Imperial28 passages
• Grant SP4005, Genesis Research Trust, Lauren Page Trust, Biomedical Research Centre at Imperial College31 passages
• Group, Institute for Biomedical Research, University of Birmingham,30 passages
• Hepatology5160 passages
• Institute and Massachusetts Eye and Ear Infirmary43 passages
• Institute – Donostia University Hospital, Paseo del Dr. Begiristain s/n, E‐20014, San Sebastian,36 passages
• Institute, City of Hope National Medical Center31 passages
• Institute, Ninewells Hospital, University of DundeeDundee, UKAddress reprint requests to:29 passages
• InstituteCanadian Institutes of Health ResearchGenome Canada and35 passages
• InstituteDurhamNC222 passages
• Laboratories, Wellcome Trust‐MRC Institute of Metabolic Science, Addenbrooke's HospitalUniversity of CambridgeCambridgeUnited Kingdom6 Liver Unit, Department of MedicineCambridge University44 passages
• Laboratory, CMM L8:04Department of Medicine, Karolinska Institute Karolinska University33 passages
• Network (RD16/0025/0017), which is included in the43 passages
• Original ArticlesAutoimmune, Cholestatic and Biliary DiseaseA randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis Kowdley et al.Kowdley et al.Kowdley40 passages
• Original ArticlesAutoimmune, Cholestatic and Biliary DiseaseFine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease Blokker et al.Blokker44 passages
• Original ArticlesHepatobiliary MalignanciesThe Antiresection Activity of the X Protein Encoded by Hepatitis43 passages
• Original ArticlesLiver Biology/PathobiologyA Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision‐Cut Liver Slices HepatologyPaish et al.Paish30 passages
• Original ArticlesLiver Biology/PathobiologyGlucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice HepatologyHoogerland et al.Hoogerland36 passages
• Original ArticlesLiver Failure/Cirrhosis/Portal HypertensionThe Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation HepatologyOey, Van Tilburg et al.Oey28 passages
• Original ArticlesLiver Injury/RegenerationExosomal Transport of Hepatocyte‐Derived Drug‐Modified Proteins to the Immune System Ogese et al.Ogese43 passages
• Original ArticlesLiver Injury/RegenerationHepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes HepatologyRussell et alRussell38 passages
• Original ArticlesLiver Injury/RegenerationPeribiliary Glands Are Key in Regeneration of the Human Biliary Epithelium After Severe Bile Duct Injury Hepatologyde Jong, Matton, et al.de Jong34 passages
• Original ArticlesSteatohepatitis/Metabolic Liver DiseaseThe Genetic Architecture of Diet‐Induced Hepatic Fibrosis in Mice Hui et al.Hui30 passages
• Original ArticlesSteatohepatitis/Metabolic Liver DiseaseThe Nonsteroidal33 passages
• Original ArticlesViral HepatitisAdvancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic44 passages
• Original ArticlesViral HepatitisCD2‐Associated Protein Contributes to32 passages
• Original ArticlesViral HepatitisDirect Inhibition of28 passages
• Original ArticlesViral HepatitisEarly Seroreversion After 2 Doses of29 passages
• Original ArticlesViral HepatitisEvolutionary Pathways to Persistence of Highly Fit and Resistant40 passages
• Original ArticlesViral HepatitisGlecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With32 passages
• Original ArticlesViral HepatitisHepatitis B Virus Virions Produced Under Nucleos(t)ide Analogue Treatment Are Mainly Not Infectious Because of30 passages
• Original ArticlesViral HepatitisHighly Diverse39 passages
• Original ArticlesViral HepatitisHost and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment van Campenhout, van Bömmel, et al.van Campenhout23 passages
• Original ArticlesViral HepatitisImpact of All‐Oral Direct‐Acting Antivirals on Clinical and Economic Outcomes in Patients With Chronic42 passages
• Original ArticlesViral HepatitisImpact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for38 passages
• Original ArticlesViral HepatitisLedipasvir‐Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic24 passages
• Original ArticlesViral HepatitisModeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort Kondili et al.Kondili35 passages
• Original ArticlesViral HepatitisPharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic20 passages
• Original ArticlesViral HepatitisSofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With36 passages
• Oslo University Hospital–The Norwegian Radium HospitalOsloNorway2 Centre for Cancer Biomedicine, Faculty of MedicineUniversity of OsloOsloNorway329 passages
• ReviewPlatelets: No longer bystanders in liver disease Liver Biology/PathobiologyChauhan et al.Chauhan26 passages
• ReviewsBile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives Hepatology, Vol. XX, No. X, 2016 Arab et al.Arab et al.Arab35 passages
• ReviewsRisk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists Hepatology, Vol. XX, No. X, 2015 Trivedi et al.Trivedi et al.Trivedi50 passages
• Service, Central Texas Veterans Health Care SystemTemple, TX6 Division of Gastroenterology and Hepatology, Mayo Clinic School of MedicineRochester, MNAddress reprint requests to:29 passages
• The University of Edinburgh39 passages
• The University of Hong KongHong Kong2 Department of PathologyThe University of Hong KongHong Kong* ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO:38 passages
• UK–UCL Centre grant (C416/A18088) and the Cancer Immunotherapy Accelerator Award (C33499/A20265) from Cancer37 passages
• Unit based at the University Hospitals36 passages
• Unit in Gastrointestinal and Liver diseases at Nottingham University27 passages
• Unit, Academic Medical CenterAmsterdam, the NetherlandsAddress reprint requests to:30 passages
• UnitUniversity of BirminghamBirminghamUnited Kingdom2 Institute of Immunology and ImmunotherapyUniversity of Birmingham, BirminghamUnited Kingdom3 Clinical Immunology DepartmentUniversity Hospital28 passages
• University of California Berkeley39 passages
• University of OxfordOxfordUnited Kingdom2 The Royal Melbourne HospitalMelbourneVictoriaAustralia3 The Royal Cornwall HospitalTruroUnited Kingdom4 Oxford University47 passages